Litigation Details for Mallinckrodt IP Unlimited Company v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Mallinckrodt IP Unlimited Company v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-12-28 |
Court | District Court, D. Delaware | Date Terminated | 2018-05-30 |
Cause | 35:0145 | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 6,992,218; 9,399,012; 9,610,265 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Mallinckrodt IP Unlimited Company v. Aurobindo Pharma USA, Inc.
Details for Mallinckrodt IP Unlimited Company v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-12-28 | 1 | sub-licensee of U.S. Patent No. 6,992,218 (“the ’218 patent), and the assignee of U.S. Patent Nos. 9,399,012…]n further respect of U.S. Patent No. 6,992,218, claims 1-19 of the patent are not infringed by Aurobindo…9,399,012 (“the ’012 patent”) and 9,610,265 (“the ’265 patent”) (collectively, the “patents-in-suit”). … action for infringement of the patents-in-suit pursuant to the Patent Laws of the United States, 35 …action involves patents that were at issue in other actions before this Court. The ’218 patent was at issue | External link to document | |
2018-07-20 | 16 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Numbers 6,992,218 B2 ;9,399,012 B2 ;9,… 2017 30 May 2018 1:17-cv-01877 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2017-12-28 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,992,218 B2; 9,399,012 B2; 9,610,265… 2017 30 May 2018 1:17-cv-01877 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |